1. Farell G: Fanconi's familial hypoplastic anemia with some unusual features. Med J Aust 1:116, 1976
2. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (FA) 1. Clinical aspects. Sem Hematol 4:233, 1967
3. Piette WW, Seabury SM: A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vasculitis in adults (Henoch-Schonlein purpura). Arch Dermatol 125:53, 1989
4. Tchou PK, Kohn T: Dyskeratosis congenita: An autosomal dominant disorder. J Am Acad Dermatol 6(6):1034-1039, 1982
5. Goldblatt J, Beighton P: Cutaneous manifestations of Gaucher disease. Br J Dermatol 111(3):331-334, 1984
6. Joliffe DS, Sarkany I: Niemann-Pick type III and Crohn's disease. J R Soc Med 76(4):307-308, 1983
7. Mardini M et al: Niemann-Pick disease: Report of a case with skin involvement. Am J Dis Childhood 136:650, 1982
8. Bolognia JL, Pawelek J: Biology of hyperpigmentation. J Am Acad Dermatol 19:217, 1988
9. Blume RS, Wolff SM: The Chediak-Higashi syndrome: Studies in four patients and a review of the literature. Medicine (Baltimore) 51(4):247-280, 1972
10. Griscelli C et al: A syndrome associating partial albinism and immunodeficiency. Am J Med 65:691, 1978
11. Howard T et al: The 47-kD protein increased in neutrophil actin dysfunction with 47- and 89-kD protein abnormalities is lymphocyte-specific protein. Blood 83:231, 1994
12. Thrasher AJ: New insights into the biology of Wiskott-Aldrich syndrome (WAS). Hematology Am Soc Hematol Educ Program :132-138, 2009
13. Bayle P et al: Neutrophilic dermatosis: A case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology 189:69, 1994
14. Younus J, Ahmed AR: The relationship of pemphigus to neoplasia. J Am Acad Dermatol 23(3 Pt 1):498-502, 1990
15. Kaplan I et al: Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncology 40(6):553-562, 2004
16. Whitworth S et al: Acquired immunobullous disease: A cutaneous manifestation of IgM macroglobulinemia. Br J Dermatol 135:283, 1996
17. McEvoy MT, Connolly SM: Linear IgA dermatosis: Association with malignancy. J Am Acad Dermatol 22(1):59-63, 1990
18. Avshalumov K et al: Bullous mastocytosis: Report of a patient and a brief review of the literature. Am J Dermatopathol 30(5):455-457, 2008
19. Weller PF: The idiopathic hypereosinophilic syndrome. Blood 83:2759, 1994
20. Levi F et al: Non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and skin cancers. Br J Cancer 74:1847, 1996
21. Milone G et al: Cutaneous vasculitis in non-Hodgkin lymphoma. Haematologica 80:529, 1995
22. Pavlidis N et al: Cutaneous lymphocytc vasculopathy in lymphoproliferative disorders-A paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 16:477, 1995
23. Ruiz-Maldonado R et al: Edematous, scarring vasculitic panniculitis: A new multisystem disease with malignant potential. J Am Acad Dermatol 32:37, 1995
24. Duncan PG, Kobrinsky N: Prilocaine-induced methemoglobinemia in a newborn infant. Anesthesiology 59(1):75-76, 1983
25. Handfield-Jones S et al: Aquagenic pruritus associated with juvenile xanthogranuloma. Clin Exp Dermatol 18:253, 1993
26. Davis MDP et al: Natural history of erythromelalgia: Presentation and outcome in 168 patients. Arch Dermatol 136:330, 2000
27. Cohen JS: Erythromelalgia: New theories and new therapies. J Am Acad Dermatol 43:841, 2000
28. AB Fleischer J. and R.S. D: Livedo reticularis. Dermatol Clin 8:347, 1990
29. Picascia DD, Pellegrini R: Livedo reticularis. Cutis 39:429, 1987
30. Pereira A et al: Anti-Sa cold agglutinin of IgA class requiring plasma-exchange therapy as early manifestation of multiple myeloma. Ann Hematol 66:315, 1993
31. Maroon M: Polycythemia rubra vera presenting as livedo reticularis. J Am Acad Dermatol 26:264, 1992
32. Weinstein S, Piette WW: Cutaneous manifestations of antiphospholipid antibody syndrome. Hematol Oncol Clin North Am 22(1):67-77, 2008
33. Nahass GT: Antiphospholipid antibodies and the antiphospholipid syndrome. J Am Acad Dermatol 36:149, 1997
34. Weir N et al: Livedo reticularis asociated with hereditary protein C deficiency and recurrent thromboembolism. Br J Dermatol 132:283, 1995
35. Gross A et al: Heparin-associated thrombocytopenia and thrombosis (HATT) presenting with livedo reticularis. Int J Dermatol 32:276, 1993
36. Frankel D et al: Acral lividosis–A sign of myeloproliferative diseases. Hyperleukocytosis syndrome in chronic myelogenous leukemia. Arch Dermatol 123:921, 1987
37. Speight EL, Lawrence CM: Reticulate purpura, cryoglobulinaemia, and livedo reticularis. Br J Dermatol 129:319, 1993
38. Hasegawa H et al: Multiple myeloma-associated systemic vasculopathy due to crystal globulin or polyarteritis nodosa. Arth Rheum 39:1996, 1996
39. Ball N et al: Crystal globulinemia syndrome. A manifestation of multiple myeloma. Cancer 71:1231, 1993
40. Lipsker D et al: The AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: Report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage. Medicine (Baltimore) 82(1):51-59, 2003
41. Turchin I, Barankin B, Schloss E: Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis. Int J Dermatol 45(10):1215-1217, 2006
42. Furie R et al: Syndrome of acquired factor X deficiency and systemic amyloidosis. N Engl J Med 297:81, 1977
43. Carroll C et al: Atrophic outpouchings of abdominal skin. Arch Dermatol 132:223, 1996
44. Lipsker D et al: Examination of cutaneous macroglobulinosis by immunoelectron microscopy. Br J Dermatol 135:287, 1996
45. Jenkins R et al: Cutaneous crystalline deposits in myeloma. Arch Dermatol 130:484, 1994
46. Radder CM: The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterin platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 191(3):815-820, 2004
47. Requena L et al: Follicular spicules of the nose: A peculiar cutaneous manifestation of multiple myeloma with cryoglobulinemia. J Am Acad Dermatol 32:834, 1995
48. Dineen A, Dicken C: Scleromyxedema. J Am Acad Dermatol 33:37, 1995
49. Crocker A, Farber S: Niemann-Pick disease: A review of 18 patients. Medicine (Baltimore) 37:1, 1958
50. Griffiths W, Daneshbod K: Pseudoxanthomatous mastocytosis. Br J Dermatol 93:91, 1975
51. Jubert C et al: Anetoderma may reveal cutaneous plasmacytoma and benign cutaneous lymphoid hyperplasia. Arch Dermatol 131:365, 1995
52. Warkentin T: Heparin-induced skin lesions. Br J Haematol 92:494, 1960
53. Rapini R: Multicentric reticulohistiocytosis. Clin Dermatol 11:107, 1993
54. Kijk EV: Ichthyosiform atrophy of the skin with internal malignant disease. Dermatologica 127:413, 1963
55. Ellis D and Y. R: Sign of Leser-Trelat. Clin Dermatol 11:141, 1993
56. Bull R et al: Eosinophilic folliculitis: A self-limiting illness in patients being treated for haematological malignancy. Br J Dermatol 129:178, 1993
57. du Peloux Menage H, Greaves MW: Aquagenic pruritus. Semin Dermatol 14:313, 1995
58. Tharp MD, Chan IJ: Mastocytosis Adv Dermatol 19:207-236, 2003
59. Schmuth M et al: Cutaneous involvement in preymphomatous angioimmunoblastic lymphadenopathy. J Am Acad Dermatol 36:290, 1997
60. Gross A et al: Fever, maculopapular eruption, and lymphadenopathy. Angioimmunoblastic lymphadenopathy (AIL). Arch Dermatol 130:1551, 1994
61. Aractingi S et al: Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol 132:535, 1996
62. Piette W: Hematologic associations of leg ulcers. Clin Dermatol 3/4:66, 1990
63. Weller P, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 83(10):2759-2779, 1994
64. Piette WW: Hematologic associations of skin ulcers. Clin Dermatol 3/4:66, 1990
65. Douglas M et al: Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, pp. 1815-1843
66. Kujovich JL: Hemostatic defects in end stage liver disease. Critical Care Clinics 21(3):563-587, 2005
67. Piette WW: The differential diagnosis of purpura from a morphologic perspective. Advances Dermatology 9:3-23, 1994
68. Piette WW: Purpura. In: Dermatological Signs of Internal Disease, edited by JP Callen et al. Philadelphia, Saunders, 2009, p. 85-92
69. George JN, Aster RH: Drug-induced thrombocytopenia: Pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program :153-158, 2009
70. Piette WW: Cutaneous manifestations of leukemias, myelodysplastic and myeloproliferative syndromes, and systemic leukemias. In: Dermatological Signs of Internal Disease, edited by JP Callen et al. Saunders. 2009, pp. 125-134
71. Kurzrock R, Cohen P: Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 99:207, 1995
72. Dominey AM, Tschen JA: Cutaneous manifestations of dysproteineimias. Dermatol Clin 7(3):449-466, 1989
73. Robson JK, Piette WW: The presentation and differential diagnosis of cutaneous vascular occlusion. Advances Dermatology 15:153, 1999
74. Kaplan RN: Differential diagnosis and management of thrombocytopenia in childhood. Pediatr Clin North Am 51(4):1109-1140, 2004
75. Tarantino MD: The pros and cons of drug therapy for immune thrombocytopenic purpura in children. Hematol Oncol Clin North Am 18(6):1301-1314, 2004
76. Mazer BD: Immune supplementation and immune modulation with intravenous immunoglobulin. J Allergy Clin Immunol 116(4):941-944, 2005
77. Sadler JE, Mortimer P: Antibody-mediated thrombotic disorders: thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia. In: Williams Hematology, edited by K Kaushanshky et al. New York, McGraw-Hill, 2010, pp. 2163-2183
78. Zhou Z, N.T. C, D.J. F: Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Sem Thromb & Hemostasis 36(1):71-81, 2010
79. Moake J: Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol 22(4):567-576, 2009
80. Srinivasan AF et al: Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Int Med 164(1):66-7066, 2004
81. Levi M, Seligsohn U: Disseminated intravascular coagulation. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, pp. 2101-2120
82. Gando S: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 34(3):625-631, 2006
83. Spicer TE, Ran IM: Purpura fulminans. Am J Med 61:566, 1976
84. Marlar RA, Neumann A: Neonatal purpura fulminans fure to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 16, 1990
85. Lichtman MA, Beutler E: Initial approach to the patient: History and physical examination. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, p. 3-10
86. Prchal JT: Clinical manifestations and classification of erythrocyte disorders. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, pp. 455-462
87. Beutler E: Disorders of iron metabolism. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, pp. 565-606
88. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 352:1011, 2005
89. Cornuz J, Guessous I, Favrat B: Fatigue: A practical approach to diagnosis in primary care. CMAJ 174(6):765-767,765 2006
90. Tews MC, Shah SM, Gossain VV: Hypothyroidism: Mimicker of common complaints. Emerg Med Clin North Am 23(3):649-667, 2005
91. Ridley CM: Pigmentation of fingertips and nails in vitamin B12 deficiency. Br J Dermatol 97(1):105-106, 1977
92. Dowham TF 2nd, Rehbein HM, Taylor KE: Hyperpigmentation and folate deficiency. Arch Dermatol 112(4):562, 1976
93. Andres E: Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 171(3):251-259, 2004
94. Robbins JM: A trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol 192:1126, 2005
95. Stuart BJ: Polycythemia vera. Am Fam Physician 69:2139, 2004
96. Davis MD: Histopathologic findings in primary erythromelalgia are nonspecific: Special studies show a decrease in small nerve fiber density. J Am Acad Dermatol 55:519, 2006
97. Prchal JT, P.J. F, Polycythemia vera. In: Williams Hematology, edited by K Kaushansky et al. New York, McGraw-Hill, 2010, pp. 1223-1236
98. Levitas A et al: Positional cyanosis in infants: An unusual presentation of right-sided cardiac masses. Cardiol Young 14:46, 2004
99. Morphet JA: Osler-Weber-Rendu syndrome. CMAJ 175:1243, 2006
100. Modena A: Fetuses with congenital heart disease demonstrate signs of decreased cerebral impedance. Am J Obstet Gynecol 195:706, 2006
101. Rosen P et al: Failure of methyene blue treatment in toxic methemoglobinemia: Associations with glucose-6-phosphate deficiency. Ann Intern Med 75:83, 1971
102. Patel B et al: Cutaneous extramedullary hematopoiesis. J Am Acad Dermatol 32:805, 1995
103. Piette WW: Dysproteinemia, plasma cell disorders, and amyloidosis. In: Dermatological Signs of Internal Disease, edited by JP Callen et al. Saunders. 2009, pp. 135-148
104. Veneri D et al: Thrombocytopenias: A clinical point of view. Blood Transfus 7:75-85, 2009
105. Piette WW: Primary systemic vasculitis. In: Cutaneous Manifestations of Rheumatic Diseases, edited by RD Sontheimer, P.T. T, Baltimore, Williams & Wilkins, 1996, p. 559